Bullboard - Stock Discussion Forum Algernon Pharmaceuticals Inc. C.AGN

Alternate Symbol(s): AGNPF

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed therapeutic drugs in the areas of non-alcoholic steatohepatitis (NASH), a type of liver disease, chronic kidney disease (CKD), inflammatory bowel disease (IBD), idiopathic pulmonary fibrosis (IPF) and chronic cough as well as advancing a stroke program using N, N... see more

CSE:AGN - Post Discussion

Algernon Pharmaceuticals Inc. > AGN DMT research featured in the Green Market Report

View:

Post by StockHawk1 on Jan 12, 2023 2:56pm

AGN DMT research featured in the Green Market Report

Algernon Pharmaceuticals (AGN.c AGNPF) is up on the CSE again today

The pharma development company was featured in The Green Market Report for its research on DMT for the treatment of stroke.

The article highlights how large this opportunity is for AGN, with the global stroke treatment market expected to reach $15B in 5 years. AGN itself values the psychedelic DMT research program at $20M.

IMO this article is required reading for anyone interested in investing in AGN as it details all the progress the company has made on this study so far, as well as AGN's future plans

https://www.greenmarketreport.com/algernon-pharmaceuticals-looks-to-advance-dmt-stroke-research/